PubRank

Xavier Mirabel

Author PubWeight™ 34.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010 7.29
2 Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. Ann Surg 2013 2.70
3 Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 2012 2.62
4 Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. J Clin Oncol 2012 1.74
5 Radiotherapy alone for primary Merkel cell carcinoma. Arch Dermatol 2003 1.55
6 Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys 2011 1.26
7 Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy. Radiat Oncol 2012 1.01
8 Primary mucosal melanoma of head and neck: prognostic value of clear margins. Laryngoscope 2006 1.00
9 Stereotactic body radiation therapy for hepatocellular carcinoma: prognostic factors of local control, overall survival, and toxicity. PLoS One 2013 1.00
10 Image-guided robotic stereotactic radiation therapy with fiducial-free tumor tracking for lung cancer. Radiat Oncol 2012 0.95
11 A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases. Radiat Oncol 2012 0.93
12 Extracranial stereotactic radiotherapy: preliminary results with the CyberKnife. Onkologie 2009 0.92
13 Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results. Radiat Oncol 2011 0.89
14 Palliative chemotherapy does not improve survival in metastatic esophageal cancer. Oncology 2010 0.86
15 Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102. J Clin Oncol 2007 0.85
16 Radiotherapy alone for Merkel cell carcinoma: a comparative and retrospective study of 25 patients. J Am Acad Dermatol 2011 0.85
17 Oral metronomic cyclophosphamide in elderly with metastatic melanoma. Invest New Drugs 2009 0.83
18 Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking. Radiat Oncol 2013 0.82
19 Ineffectiveness of ¹⁸F-fluorodeoxyglucose positron emission tomography in the evaluation of tumor response after completion of neoadjuvant chemoradiation in esophageal cancer. Ann Surg 2013 0.82
20 Adjuvant radiation therapy in metastatic lymph nodes from melanoma. Radiat Oncol 2011 0.82
21 [Frequency of genetic diseases and cancer antecedents in 493 adults with visceral or soft tissue sarcomas]. Bull Cancer 2003 0.82
22 Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03). Radiother Oncol 2008 0.82
23 [Radiation-induced skin reactions (except malignant tumors)]. Bull Cancer 2003 0.80
24 Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer? Int J Radiat Oncol Biol Phys 2013 0.80
25 Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome. BMC Cancer 2013 0.76
26 Have we established a stereotactic body radiotherapy regimen for liver metastases? J Clin Oncol 2009 0.75
27 Reply to R. Glynne-Jones et al. J Clin Oncol 2013 0.75
28 Cetuximab with concurrent chemoradiation for esophagogastric cancer: in regard to Safran et al. (Int J Radiat Oncol Biol Phys 2008;70:391-395). Int J Radiat Oncol Biol Phys 2008 0.75
29 Esophageal Adenocarcinoma: Impact of a Large Hiatal Hernia on Outcomes After Surgery. Ann Surg 2016 0.75
30 [Merkel cell carcinoma: current diagnosis and treatment]. Bull Cancer 2008 0.75
31 External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys 2006 0.75